# Effects of Infusion Timing on Treatment Response in Solid Tumors

> **NCT07630168** · PHASE2 · RECRUITING · sponsor: **UNC Lineberger Comprehensive Cancer Center** · enrollment: 238 (estimated)

## Conditions studied

- Lung Cancer
- Non-small Cell Lung Cancer
- Metastatic Lung Cancer
- Head and Neck Cancer
- Metastatic Squamous Cell Carcinoma
- Metastatic Head and Neck Cancer
- Resectable Head and Neck Squamous-cell Carcinoma

## Interventions

- **DRUG:** PD-1/PD-L1 inhibitor monotherapy - 4 cycles before 12:00PM
- **DRUG:** PD-1/PD-L1 inhibitor monotherapy - 4 cycles after 3 PM
- **DRUG:** PD-1 inhibitor monotherapy - 2 cycles before 12:00PM
- **DRUG:** PD-1 inhibitor monotherapy - 2 cycles after 3 PM

## Key facts

- **NCT ID:** NCT07630168
- **Lead sponsor:** UNC Lineberger Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-03
- **Primary completion:** 2033-01-01
- **Final completion:** 2033-01-01
- **Target enrollment:** 238 (ESTIMATED)
- **Last updated:** 2026-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07630168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07630168, "Effects of Infusion Timing on Treatment Response in Solid Tumors". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07630168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*